We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Seneca Growth Capital Vct Plc | LSE:HYG | London | Ordinary Share | GB0031256109 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 13.50 | 10.00 | 17.00 | 13.50 | 13.50 | 13.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Trust,ex Ed,religious,charty | -2.26M | -2.75M | -0.0950 | -6.37 | 17.5M |
TIDMHYG
Hygea VCT plc
24 February 2016
For immediate release 24 February 2016
Hygea vct plc
Scancell plc to present at Biotech Capital in London on 3rd March 2016
The Board of Hygea vct plc announces that Hygea's largest investment by value, Scancell plc (www.scancell.co.uk), is presenting at the Biotech Capital Conference being held in London on 3rd March 2016. Attendance is free, with registration via www.biotech-capital.com/conferences - a recording of the event will be posted on the website. An article Immunotherapy: a turning point in cancer treatment by Vadim Alexandre can be found on page 8 of the AIM Journal (http://www.hubinvest.com/AIMPDFFebruary2016_77.pdf).
Enquiries: Charles Breese, director on 01280 703482
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAUSSRRNAAUUAR
(END) Dow Jones Newswires
February 24, 2016 05:42 ET (10:42 GMT)
1 Year Seneca Growth Capital Vct Chart |
1 Month Seneca Growth Capital Vct Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions